Papers in BJC Reports
Page 1 · newest first
- Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcomaBJC Reports · 2026
- Human papillomavirus 16 genomic variation in head and neck cancer: a systematic review with structural and functional annotationBJC Reports · 2026
- The Cost of Uncertainty: A Microcosting Analysis of the Cancer of Unknown Primary Diagnostic PathwayBJC Reports · 2026
- Development of functional spatial mapping of the tumour immune microenvironment (FuncO:TiME) in advanced melanomasBJC Reports · 2026
- MiR-662 impairs C/D box snoRNA expression and rRNA 2′-O-ribose methylation marksBJC Reports · 2026
- Immune remodeling and myeloid signature in the bone marrow niche of MYCN-driven neuroblastomaBJC Reports · 2026
- A comprehensive analysis of lung cancer status changes over 10 years: results of Moroccan cohortBJC Reports · 2026
- Mucosal melanoma in 1481 patients in the Netherlands. An overview of metastatic patterns, main driver mutations and the efficacy of therapeutic strategiesBJC Reports · 2026
- Frequency of exercise and cancer-related fatigue among patients with lymphomaBJC Reports · 2026
- Urinary volatilomics using liquid-liquid extraction and gas chromatography-mass spectrometry (GC-MS) combined with machine learning algorithms as a tool for diagnosis and surveillance of urothelial bladder cancerBJC Reports · 2026
- Homologous recombination deficiency (HRD) testing of high-grade serous carcinoma using cytological samplesBJC Reports · 2026
- Role of consolidative surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC): Princess Margaret Cancer Centre experienceBJC Reports · 2026
- Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case reportBJC Reports · 2026
- Outcomes from the NHS-Galleri trial: the good, the bad, and the uncertainBJC Reports · 2026
- Peribronchial cuffing: an underrecognized pattern of prostate carcinoma metastases to the lungBJC Reports · 2026
- Long-term outcomes and GVHD in allogeneic hematopoietic cell transplantation abroad: a 14-year UAE multi-center cohortBJC Reports · 2026
- Biomass burning, PM2.5 peaks, and trends in lung adenocarcinoma diagnoses: an ecological study in São Paulo State, BrazilBJC Reports · 2026
- Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomideBJC Reports · 2026
- Outcome measurement tools in pediatric oncology palliative care: a scoping review of domains, validation and contextual relevanceBJC Reports · 2026
- Prognostic significance of intratumoral neutrophil extracellular traps in pulmonary pleomorphic carcinoma: comparison with adenocarcinomaBJC Reports · 2026
- Improving cancer care while reducing its carbon footprint: GHG-mitigating strategies highlighted at ESMO 2025BJC Reports · 2026
- Duty of care: amplifying the impact of planetary health research at oncology conferencesBJC Reports · 2026
- Debate: why surgery should remain central in the management of locally advanced (Stage III) non-small-cell lung cancerBJC Reports · 2026
- The evolution of non-surgical management in stage III non-small cell lung cancerBJC Reports · 2026
- Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studiesBJC Reports · 2026
- Machine learning and artificial intelligence in liquid biopsy-based early detection of pancreatic cancer: a scoping reviewBJC Reports · 2026
- Beckwith-Wiedemann syndrome multiomic analysis of hepatoblastoma uncovers unique tumour heterogeneity and cellular landscapes, including transition cells leading to tumour formationBJC Reports · 2026
- Molecular subtypes and the (in vitro) response of glioblastoma to temozolomideBJC Reports · 2026
- 4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinomaBJC Reports · 2026
- Significance and challenges in dissecting cancer-bacteriome interactionsBJC Reports · 2026
- High expression of the ADC target Claudin-6 associates with aggressive endometrial cancer and remains high in metastatic lesionsBJC Reports · 2026
- Remarkable response of metaplastic breast cancer to a novel targeted AKT inhibitor TAS-117 in a Cowden syndrome patient: a case reportBJC Reports · 2026
- Molecular targeting of the meningioma cell signaling circuit reveals drug vulnerabilities including synergy between sulforaphane and focal adhesion kinase inhibitionBJC Reports · 2026
- Precision oncology in the age of AI: lessons from AI-driven drug discovery and clinical translationBJC Reports · 2026
- Disparities in blood cancer survival in the UK 2009–2019: national cohort studiesBJC Reports · 2026
- A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancerBJC Reports · 2026
- Editorial: focus on the COMET trialBJC Reports · 2026
- Commentary: With Regards to the WISDOM trialBJC Reports · 2026
- Obesity-associated gene mutations across cancer types: a pan-cancer analysis of TCGA dataBJC Reports · 2026
- Understanding the preferences of younger women for the delivery of a service to predict breast cancer risk: a discrete choice experimentBJC Reports · 2026
- IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistanceBJC Reports · 2026
- Patients’ responses & reflections when receiving news of cancer progression: a qualitative studyBJC Reports · 2026
- The COVID-19 pandemic has not influenced survival outcomes of head and neck cancer squamous cell carcinomas in the West of Scotland: a retrospective cohort studyBJC Reports · 2026
- Changes in levels of endocannabinoidome mediators in mice with cancer cachexia: links with steatosis and gut microbial dysbiosisBJC Reports · 2026
- An international cohort study of breast cancer survival in young womenBJC Reports · 2026
- Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenicBJC Reports · 2026
- STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancerBJC Reports · 2026
- Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic menBJC Reports · 2026
- Implementing mainstream germline genetic testing in breast cancer across EuropeBJC Reports · 2026
- Characterisation of adult patients with neuroendocrine neoplasms and their journey to diagnosisBJC Reports · 2026